Evidence map›Paper›PMID 36107774›Full record

ArticleNucleic acids research2022

Changes in the architecture and abundance of replication intermediates delineate the chronology of DNA damage tolerance pathways at UV-stalled replication forks in human cells.

Yann Benureau, Caroline Pouvelle, Pauline Dupaigne, Sonia Baconnais, Eliana Moreira Tavares, Gerard Mazón, Emmanuelle Despras, Eric Le Cam, Patricia L Kannouche

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yann BenureauUMR9019 CNRS, Genome Integrity and Cancers, Laboratory Genome Integrity, Immune Response and Cancers, Equipe Labellisée La Ligue Contre Le Cancer, Gustave Roussy 94805, Villejuif, France.
Caroline PouvelleUMR9019 CNRS, Genome Integrity and Cancers, Laboratory Genome Integrity, Immune Response and Cancers, Equipe Labellisée La Ligue Contre Le Cancer, Gustave Roussy 94805, Villejuif, France.
Pauline DupaigneUMR9019 CNRS, Genome Integrity and Cancers, Laboratory DSB Repair, Replication stress and Genome Integrity, Gustave Roussy 94805, Villejuif, France.ORCID 0000-0001-7033-4055
Sonia BaconnaisUMR9019 CNRS, Genome Integrity and Cancers, Laboratory DSB Repair, Replication stress and Genome Integrity, Gustave Roussy 94805, Villejuif, France.ORCID 0000-0003-1350-6441
Eliana Moreira TavaresUMR9019 CNRS, Genome Integrity and Cancers, Laboratory DSB Repair, Replication stress and Genome Integrity, Gustave Roussy 94805, Villejuif, France.
Gerard MazónUMR9019 CNRS, Genome Integrity and Cancers, Laboratory DSB Repair, Replication stress and Genome Integrity, Gustave Roussy 94805, Villejuif, France.ORCID 0000-0002-9791-5666
Emmanuelle DesprasUMR9019 CNRS, Genome Integrity and Cancers, Laboratory Genome Integrity, Immune Response and Cancers, Equipe Labellisée La Ligue Contre Le Cancer, Gustave Roussy 94805, Villejuif, France.ORCID 0000-0003-3331-1748
Eric Le CamUMR9019 CNRS, Genome Integrity and Cancers, Laboratory DSB Repair, Replication stress and Genome Integrity, Gustave Roussy 94805, Villejuif, France.ORCID 0000-0002-6832-6117
Patricia L KannoucheUMR9019 CNRS, Genome Integrity and Cancers, Laboratory Genome Integrity, Immune Response and Cancers, Equipe Labellisée La Ligue Contre Le Cancer, Gustave Roussy 94805, Villejuif, France.ORCID 0000-0002-6050-3457
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA lesions in S phase threaten genome stability. The DNA damage tolerance (DDT) pathways overcome these obstacles and allow completion of DNA synthesis by the use of specialised translesion (TLS) DNA polymerases or through recombination-related processes. However, how these mechanisms coordinate with each other and with bulk replication remains elusive. To address these issues, we monitored the variation of replication intermediate architecture in response to ultraviolet irradiation using transmission electron microscopy. We show that the TLS polymerase η, able to accurately bypass the major UV lesion and mutated in the skin cancer-prone xeroderma pigmentosum variant (XPV) syndrome, acts at the replication fork to resolve uncoupling and prevent post-replicative gap accumulation. Repriming occurs as a compensatory mechanism when this on-the-fly mechanism cannot operate, and is therefore predominant in XPV cells. Interestingly, our data support a recombination-independent function of RAD51 at the replication fork to sustain repriming. Finally, we provide evidence for the post-replicative commitment of recombination in gap repair and for pioneering observations of in vivo recombination intermediates. Altogether, we propose a chronology of UV damage tolerance in human cells that highlights the key role of polη in shaping this response and ensuring the continuity of DNA synthesis.

Indexed as

DNA RepairXeroderma PigmentosumDNA DamageDNA-Directed DNA PolymeraseDNA ReplicationHumansUltraviolet RaysDNA-Directed DNA Polymerase

Identifiers

PMID36107774
PMCPMC9508826
OpenAlexW4295893237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.